These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34728109)

  • 1. [Interest of a geostatistical approach to analyze the geographical disparities in human papillomavirus vaccine coverage in France].
    Ribassin-Majed L; Pereira M; Magneron C; Levy-Bachelot L; Fagherazzi G; Baldauf JJ; Raude J
    Rev Epidemiol Sante Publique; 2021 Nov; 69(6):321-328. PubMed ID: 34728109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: Results of the Health, Health Care and Insurance Survey, 2012.
    Guthmann JP; Pelat C; Célant N; Parent du Chatelet I; Duport N; Rochereau T; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2017 Apr; 65(2):109-117. PubMed ID: 28238476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HPV prophylactic vaccine coverage and factors impacting its practice among students and high school students in Marseilles' area].
    Baudoin A; Sabiani L; Oundjian F; Tabouret E; Agostini A; Courbière B; Boubli L; Carcopino X
    J Gynecol Obstet Biol Reprod (Paris); 2015 Feb; 44(2):126-35. PubMed ID: 24703591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of geographic inequalities in HPV vaccination in the most populated region of France.
    Héquet D; Rouzier R
    PLoS One; 2017; 12(3):e0172906. PubMed ID: 28257434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding vaccination competencies to community pharmacists: modelling the organizational and economic impacts of new human papilloma virus (HPV) vaccine pathways in France.
    Julia B; Foerst C; Akarkoub S; Azzazene S; Grémaud N; Sénégas RO; Mourlat B; Mamane C; Bensimon L; Farge G
    BMC Health Serv Res; 2024 Jul; 24(1):845. PubMed ID: 39061059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccines in Picardy, France: coverage and correlation with socioeconomic factors.
    Ganry O; Bernin-Mereau AS; Gignon M; Merlin-Brochard J; Schmit JL
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):447-54. PubMed ID: 24016739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practices and attitudes regarding HPV vaccination among general practitioners from Besançon].
    Bouvret P; Mougin C; Prétet JL; Meurisse A; Bonnetain F; Fiteni F
    J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):972-978. PubMed ID: 26780841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017.
    Walker TY; Elam-Evans LD; Williams CL; Fredua B; Yankey D; Markowitz LE; Stokley S
    Hum Vaccin Immunother; 2020 Mar; 16(3):554-561. PubMed ID: 31662024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study.
    Dalon F; Majed L; Belhassen M; Jacoud F; Bérard M; Lévy-Bachelot L; de Pouvourville G; Rouzier R; Raude J; Baldauf JJ
    Vaccine; 2021 Aug; 39(36):5129-5137. PubMed ID: 34334252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
    Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillomavirus and cancers: should we extend vaccination to boys in France?
    Abramowitz L; Descamps P; Denis F; Dommergues MA; Pradat P; St Guily JL; Judlin P
    J Public Health (Oxf); 2017 Dec; 39(4):e229-e234. PubMed ID: 27679660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Area-Level Disparities in Human Papillomavirus Vaccination Coverage Using Geospatial Analysis.
    Wheeler DC; Miller CA; Do EK; Ksinan AJ; Trogdon JG; Chukmaitov A; Fuemmeler BF
    Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1689-1696. PubMed ID: 34172461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
    Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
    J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups.
    Latsuzbaia A; Arbyn M; Weyers S; Mossong J
    Vaccine; 2018 Apr; 36(18):2411-2416. PubMed ID: 29602702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV Vaccination Coverage Among US Teens Across the Rural-Urban Continuum.
    Swiecki-Sikora AL; Henry KA; Kepka D
    J Rural Health; 2019 Sep; 35(4):506-517. PubMed ID: 30703854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine coverage among females aged 11 to 17 in Texas counties: an application of multilevel, small area estimation.
    Eberth JM; Hossain MM; Tiro JA; Zhang X; Holt JB; Vernon SW
    Womens Health Issues; 2013; 23(2):e131-41. PubMed ID: 23481692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
    Huon JF; Grégoire A; Meireles A; Lefebvre M; Péré M; Coutherut J; Biron C; Raffi F; Briend-Godet V
    PLoS One; 2020; 15(10):e0234693. PubMed ID: 33091021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.
    Uhart M; Adam M; Dahlab A; Bresse X
    Papillomavirus Res; 2017 Jun; 3():73-79. PubMed ID: 28720460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe.
    Nguyen-Huu NH; Thilly N; Derrough T; Sdona E; Claudot F; Pulcini C; Agrinier N;
    Vaccine; 2020 Feb; 38(6):1315-1331. PubMed ID: 31836255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
    Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
    BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.